Cytori Therapeutics Inc (NASDAQ:CYTX)

0.9505
Delayed Data
As of Jul 20
 -0.0245 / -2.51%
Today’s Change
0.91
Today|||52-Week Range
11.40
-68.48%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$5.9M

Company Description

Cytori Therapeutics, Inc. is a late stage cell therapy company which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical trials. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in San Diego, CA.

Contact Information

Cytori Therapeutics, Inc.
3020 Callan Road
San Diego California 92121
P:(858) 458-0900
Investor Relations:

Employees

Shareholders

Other institutional14.56%
Mutual fund holders1.43%
Individual stakeholders--

Top Executives

Marc H. HedrickPresident, Chief Executive Officer & Director
Tiago GirãoCFO & Principal Accounting Officer
Mark T. MarinoChief Medical Officer & Senior Vice President
John K. FraserChief Scientist
Jeremy HaydenVP-Business Development & General Counsel